| Dorothy Virginia Freeman, MD | |
|
21 Washburn Ave, Wellesley, MA 02481-5263 | |
| (781) 431-7412 | |
| Not Available |
| Full Name | Dorothy Virginia Freeman |
|---|---|
| Gender | Female |
| Speciality | Surgery - Vascular Surgery |
| Location | 21 Washburn Ave, Wellesley, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750697157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 54548 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dorothy Virginia Freeman, MD 21 Washburn Ave, Wellesley, MA 02481-5263 Ph: (781) 431-7412 | Dorothy Virginia Freeman, MD 21 Washburn Ave, Wellesley, MA 02481-5263 Ph: (781) 431-7412 |
News Archive
The coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has taken a toll on many countries, infecting more than 7.35 million people. Previously, scientists claimed that the virus could be transmitted via asymptomatic carriers, or those not showing symptoms of the disease.
Progranulin is a central protein in both neuronal survival and neurodegenerative diseases. It is thus not surprising that altered progranulin levels represent a universal theme shared across several common neurodegenerative diseases.
Patients with atrial fibrillation and declining renal function are at increased risk of subsequent stroke or systemic embolism, major bleeding and death, US researchers report.
Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. Researchers writing in the open access journal BMC Cancer found increased expression of GLI1 in samples taken from more advanced and less survivable tumors.
AstraZeneca and MSD (Merck) announced today that the U.S. Food and Drug Administration (FDA) has granted acceptance to file status of its application for the MEK inhibitor selumetinib, for use in patients with plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1).
› Verified 4 days ago
Dr. Laura Linda Mccann, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Washington St, Ste 300, Wellesley, MA 02481 Phone: 781-431-0151 Fax: 781-481-0152 | |
Dr. Mark Khajag Markarian, MD, MSPH Surgery Medicare: Medicare Enrolled Practice Location: 25 Walnut St, Suite 400, Wellesley, MA 02481 Phone: 781-431-0002 Fax: 781-237-2022 | |
Glenn C Harder, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 332 Washington St, Wellesley, MA 02481 Phone: 781-899-7092 | |
Robert C Savage, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 332 Washington St, Suite 205, Wellesley, MA 02481 Phone: 781-263-7333 Fax: 781-263-7337 | |
Dr. Michael Reinhorn, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 20 Walnut St Ste 100, Wellesley, MA 02481 Phone: 617-466-3373 | |
Joseph Charles Avellone Iii, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 21 Elm St, Wellesley, MA 02481 Phone: 781-237-6246 | |
Dr. Pamela Hillyard Cheney, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 416 Weston Rd, Wellesley, MA 02482 Phone: 781-489-5146 Fax: 339-686-3003 |